Docket #: S10-206
A diagnostic method for identifying immune system decline
A team of Stanford researchers have identified a set of biomarkers that could be used to recognize patients with age-related declines in their immune function. This Immune Senescence Signature (ISS) was characterized by analyzing peripheral blood cells from young and old adults and measuring cell subset frequencies, serum cytokines, gene expression, and response to cytokine stimulation. This data was then used to construct an immune network and characterize a cytokine non-responsive phenotype (CNR) based on the relationship between multiple factors in single individuals. ISS screening to identify patients with sub-functional immune system could be used to introduce measures for reducing their risk of morbidity or mortality from infectious diseases.
Applications
- Diagnostic screening for immune function of healthy individuals, especially elderly
Advantages
- Comprehensive range of biomarkers - the combination of several biomarkers yields more accurate assessment of immune function than assays focused on a single marker
Patents
- Published Application: 20120021414
- Issued: 10,119,959 (USA)
Similar Technologies
-
Blood test predicts insulin resistance using an iPSC (induced pluripotent stem cell) model S19-145Blood test predicts insulin resistance using an iPSC (induced pluripotent stem cell) model
-
Using machine-learning to leverage variations in DNA methylation for early lung cancer detection S22-485Using machine-learning to leverage variations in DNA methylation for early lung cancer detection
-
Biomarkers for Ovarian Cancer Diagnostics Prognostics as a Guide to Individualized Therapies S15-338Biomarkers for Ovarian Cancer Diagnostics Prognostics as a Guide to Individualized Therapies